Production (Stage)
Bellicum Pharmaceuticals, Inc.
BLCM
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -79.45% | -77.66% | -61.27% | -52.69% | 49.26% |
| Total Receivables | -98.50% | -- | -96.14% | -- | 79.86% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -38.81% | -23.68% | -6.02% | 54.77% | 48.18% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -78.10% | -76.19% | -60.30% | -51.56% | 39.94% |
|
|
|||||
| Total Current Assets | -78.10% | -76.19% | -60.30% | -51.56% | 39.94% |
| Net Property, Plant & Equipment | -70.59% | 16.67% | 71.43% | 83.33% | -37.04% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -78.09% | -76.14% | -60.26% | -51.52% | 39.82% |
|
|
|||||
| Total Accounts Payable | -26.33% | 18.30% | 478.30% | 440.00% | 37.04% |
| Total Accrued Expenses | -60.98% | 10.78% | -2.75% | -35.65% | -42.16% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -73.38% | -72.28% | -94.67% | -70.83% | -81.71% |
| Total Other Current Liabilities | -73.38% | -72.28% | -94.67% | -70.83% | -81.71% |
| Total Current Liabilities | -60.87% | -23.15% | -40.82% | -43.80% | -65.17% |
|
|
|||||
| Total Current Liabilities | -60.87% | -23.15% | -40.82% | -43.80% | -65.17% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -60.87% | -23.15% | -40.82% | -43.80% | -65.17% |
|
|
|||||
| Common Stock & APIC | -2.08% | -1.21% | -0.34% | 0.45% | 6.57% |
| Retained Earnings | -3.93% | -5.13% | -4.57% | -4.54% | -2.94% |
| Treasury Stock & Other | -0.02% | -0.20% | -0.24% | -0.30% | -0.09% |
| Total Common Equity | -460.23% | -255.59% | -157.49% | -91.74% | 161.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 75.30% | 50.21% | 25.11% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 75.30% | 50.21% | 25.11% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -460.23% | -255.59% | -157.49% | -91.74% | 161.64% |
| Total Preferred Equity | 75.30% | 50.21% | 25.11% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -81.97% | -83.63% | -64.63% | -52.74% | 334.93% |
|
|
|||||